help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SCHWARZE, J.
Right arrow Articles by GELFAND, E. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SCHWARZE, J.
Right arrow Articles by GELFAND, E. W.

Am. J. Respir. Crit. Care Med., Volume 158, Number 2, August 1998, 519-525

Antigen-specific Immunoglobulin-A Prevents Increased Airway Responsiveness and Lung Eosinophilia after Airway Challenge in Sensitized Mice

JÜRGEN SCHWARZE, GRZEGORZ CIESLEWICZ, ANTHONY JOETHAM, LEE K. SUN, WILLIAM N. SUN, TSE WEN CHANG, ECKARD HAMELMANN, and ERWIN W. GELFAND

Division of Basic Sciences, Department of Pediatrics, National Jewish Medical and Research Center, Denver, Colorado; and Tanox Biosystems, Houston, Texas

Aeroallergens such as Amb a I from short ragweed are important in the development of allergic airway disease. We tested the ability of a human monoclonal immunoglobulin-A (IgA) antibody specific for Amb a I (A-IgA) to modulate airway responsiveness and lung eosinophilia after airway challenge with nebulized Amb a I or ragweed extract in mice sensitized to Amb a I or ragweed extract, respectively. A-IgA or nonspecific IgA (C-IgA) were given intranasally up to 8 h before each challenge. Allergen challenge resulted in increases in airway responsiveness, in numbers of lung eosinophils, and in Amb a I-specific IgE levels. These were prevented by pretreatment with A-IgA but not with C-IgA. Decreases in IFN-gamma and increases in IL-4 and IL-5 production following challenge with Amb a I were also reduced by A-IgA treatment. In contrast, increases in total IgE and total IgG and in numbers of lung neutrophils after challenge were not significantly affected by A-IgA, which additionally induced increased levels of Amb a I-specific IgG2a antibodies. In mice sensitized and challenged with ovalbumin (OVA), A-IgA did not affect airway responsiveness, lung eosinophilia, cytokine production, or immunoglobulin levels. These data indicate that allergen-specific IgA can prevent airway hyperresponsiveness and reduce eosinophil influx into the lungs following allergen challenge via the airways in sensitized mice, and these effects are allergen-specific. Neutralization of allergen may contribute to the effects of IgA, but the induction of allergen-specific IgG2a in A-IgA-treated mice suggests an immunomodulatory action for A-IgA.




This article has been cited by other articles:


Home page
J. Immunol.Home page
Y. A. Taher, B. C. A. M. van Esch, G. A. Hofman, P. A. J. Henricks, and A. J. M. van Oosterhout
1{alpha},25-Dihydroxyvitamin D3 Potentiates the Beneficial Effects of Allergen Immunotherapy in a Mouse Model of Allergic Asthma: Role for IL-10 and TGF-{beta}
J. Immunol., April 15, 2008; 180(8): 5211 - 5221.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. A. Kadaoui and B. Corthesy
Secretory IgA Mediates Bacterial Translocation to Dendritic Cells in Mouse Peyer's Patches with Restriction to Mucosal Compartment
J. Immunol., December 1, 2007; 179(11): 7751 - 7757.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Pilette, K. T. Nouri-Aria, M. R. Jacobson, L. K. Wilcock, B. Detry, S. M. Walker, J. N. Francis, and S. R. Durham
Grass Pollen Immunotherapy Induces an Allergen-Specific IgA2 Antibody Response Associated with Mucosal TGF-beta Expression
J. Immunol., April 1, 2007; 178(7): 4658 - 4666.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
C. Pilette, S. R. Durham, J.-P. Vaerman, and Y. Sibille
Mucosal Immunity in Asthma and Chronic Obstructive Pulmonary Disease: A Role for Immunoglobulin A?
Proceedings of the ATS, April 1, 2004; 1(2): 125 - 135.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Sehra, G. Pynaert, K. Tournoy, A. Haegeman, P. Matthys, Y. Tagawa, R. Pauwels, and J. Grooten
Airway IgG Counteracts Specific and Bystander Allergen-Triggered Pulmonary Inflammation by a Mechanism Dependent on Fc{gamma}R and IFN-{gamma}
J. Immunol., August 15, 2003; 171(4): 2080 - 2089.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Takabayashi, L. Libet, D. Chisholm, J. Zubeldia, and A. A. Horner
Intranasal Immunotherapy Is More Effective Than Intradermal Immunotherapy for the Induction of Airway Allergen Tolerance in Th2-Sensitized Mice
J. Immunol., April 1, 2003; 170(7): 3898 - 3905.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Sandin, S. Linse, T. Areschoug, J. M. Woof, J. Reinholdt, and G. Lindahl
Isolation and Detection of Human IgA Using a Streptococcal IgA-Binding Peptide
J. Immunol., August 1, 2002; 169(3): 1357 - 1364.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1998 American Thoracic Society